Having trouble viewing this email? View in your browser.

23 January 2018

Dear colleagues,

The ESCMID study group for antimicrobial stewardship (ESGAP) published its survey evaluating the current practice and the willingness to shorten the duration of antibiotic therapy among infection specialists in the Journal of Antimicrobial Chemotherapy.

In addition, the Infectious Diseases Society of America positively reviewed ESGAP’s antimicrobial stewardship book in its journal Clinical Infectious Diseases.

EITaF publishes two new contributions on their outbreak news pages: one about yellow fever outbreak in the state of São Paolo and one about Salmonella agona and infant formula milk.

Your ESCMID communications editors


Abstract submitters informed soon; late-breaking abstracts 15 Feb – 1 Mar

Abstract submitters will be informed about acceptance before the early-bird registration deadline runs out on 25 January 2018.

The abstract submission for late-breaking abstracts will be open from 15 February to 1 March 2018. This year we will accept submission for the topics clinical trials, vaccine-preventable diseases and others.

› Read more

Evgeny Idelevich and James Price to receive Young Investigator Awards

Evgeny (left) from the Institute of Medical Microbiology, University Hospital Münster, Germany, has a strong interest in the translational approach in the diagnostics of infectious diseases with his research focusing on rapid sepsis diagnostics and rapid susceptibility testing. He has developed novel principles of sepsis diagnostics and detection of multidrug-resistant organisms, which have led to patent applications and technology transfer from academia to industry. Some methods are currently in further development funded by the German Ministry of Education and Research, and some have already been introduced into routine diagnostics.

James (right), a National Institute for Health research lecturer from the Brighton and Sussex Medical School, University of Sussex, in Brighton, United Kingdom, is focused on prevention of healthcare-associated infection, including S. aureus and other multidrug-resistant organisms. He combines developing his research interests with completing specialist training in infectious diseases and microbiology. His work utilizes whole-genome sequencing and epidemiological data to evaluate carriage, acquisition and transmission of pathogens in healthcare settings, with the aim of developing interventions to reduce nosocomial infections.  

The awardees will receive their awards during the ESCMID Young Investigator Awards Session at ECCMID. During the session, Evgeny will give his presentation Acceleration of microbiological diagnostics: it’s time to rethink! and James’ talk will be on Unravelling Staphylococcus aureus transmission: a game of catch or hide and seek?

› Read more

CMI highlight: avoid fluoroquinolones for first-line UTI therapy in primary care

Researchers quantified the impact of antibiotics prescribed in primary care for urinary tract infections (UTIs) on intestinal colonization by ciprofloxacin-resistant (CIP-RE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE). Fluoroquinolone treatment caused transient suppression of Enterobacteriaceae and subsequent two-fold increase in CIP-RE prevalence, while nitrofurans had no impact on CIP-RE. ESBL-PE were identified in 5% (107/2058) of samples from 71 (10%) participants, with colonization not associated with antibiotic exposure. Household exposure to CIP-RE or ESBL-PE was associated with increased individual risk of colonization. These findings support avoidance of fluoroquinolones for first-line UTI therapy in primary care, and suggest potential for interventions interrupting household circulation of resistant Enterobacteriaceae, the researchers conclude.

› Read more

New-look observership programme is almost ready to accept applications!

We are excited to announce the launch of the new-look observership programme. To make the programme fairer and more sustainable, some key changes have been made, including:
•    From February, members will be able to apply for non-funded observerships with our Collaborative Centres (ECCs) throughout the year
•    Young Scientist Members can apply for funded observerships during two calls per year. The first will open in the coming weeks, and you can already start preparing by contacting your preferred ECC and agreeing visit dates and objectives with them. You must supply a letter on the ECC´s letter-headed paper with the agreed dates and objectives when you apply. Applicants must also obtain a letter from their supervisor explaining how the visit will benefit the home institution
•    For funded observerships, the observership should take place between April 2018 and March 2019.
For further information about the criteria for both funded and unfunded observerships can be found on the website. The opening of both the funded and unfunded programmes will be announced in upcoming newsletters.

› Read more

Grant deadlines extended for Birmingham, Muscat, and São Paulo education courses

ESCMID extended the grant application deadlines for three postgraduate education courses: For the course Challenges in Veterinary Hospital Infection Control and Antimicrobial Stewardship on 4 April in Birmingham the grant application has been re-opened and extended to 7 February 2018. For the Workshop on Migrants’ Health from 8 – 10 March 2018 in Muscat the deadline is now 9 February 2018, and for the course Adult Immunization: New and Old Challenges from 16 – 17 March  in São Paulo has been extended to 16 February 2018.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.